Skip to the page

Data / Form D filings / RHINOCYTE INC

RHINOCYTE INC: Form D filings

RHINOCYTE INC, a biotechnology company in Louisville, KY, filed 5 Form D notices with the SEC between 2009 and 2015. The latest, on October 7, 2015, reports $250,000 sold of a $500,000 offering to 2 investors.

Find out what RHINOCYTE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1044 East Chestnut St, Louisville, KY, 40204
Phone
(502) 410-4512
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1369602

The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 7, 2015New notice$500,000$250,000$250,0002Oct 2, 2015sec.gov
Jul 8, 2014New notice$1,500,000$750,000$750,0003Jun 26, 2014sec.gov
Oct 22, 2012New notice$1,000,000$525,000$475,0006Oct 16, 2012sec.gov
Nov 18, 2011New notice$2,000,000$1,114,721$885,27918Nov 4, 2011sec.gov
Oct 15, 2009New notice$3,500,000$1,130,000$2,370,00011Sep 25, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Teresa LeezerExecutive Officer, Director
Jason J TomlinsonDirector
Steven J GailarDirector
Tony J ShipleyDirector
Dr. Fred J RoisenExecutive Officer, Director

Every Form D from the week of Oct 5, 2015 · All recent filings in Kentucky · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what RHINOCYTE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.